Gynesonics Lands $21,000,000 Series D Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4edba57f-3801-40ee-868f-4c7589dff1a0&Preview=1 - Date
2/20/2013 - Company Name
Gynesonics - Mailing Address
604 Fifth Avenue Redwood City, CA 94063 - Company Description
Gynesonics is a private company that is developing a novel, minimally invasive system to treat uterine fibroid tumors, The VizAblate system. Gynesonics’ disposable, hand-held device combines ultrasound imaging to allow the gynecologist to identify fibroids with radiofrequency energy to ablate the tumor. In addition to a simple procedure for the physician, Gynesonics same-day out patient treatment should be easier for the patient and at a far lower cost for insurers. - Website
http://www.gynesonics.com - Transaction Type
Venture Equity - Transaction Amount
$21,000,000 - Transaction Round
Series D - Proceeds Purposes
Gynesonics will use the proceeds to continue clinical and commercial development of the VizAblate(R) System, a transcervical, ultrasound-guided ablation system for the treatment of uterine fibroids. - M&A Terms
- Venture Investor
HBM Bioventures - Venture Investor
Correlation Ventures - Venture Investor
Abingworth Management - Venture Investor
Advanced Technology Ventures - Venture Investor
InterWest Partners
